Nanotechnology has made a significant impact on basic and clinical cancer research over
the past two decades. Owing to multidisciplinary advances, cancer nanotechnology aims to …

Cancer continues to pose a severe threat to global health, making pursuing effective
treatments more critical than ever. Traditional therapies, although pivotal in managing …

Cancer is a disease that seriously threatens human health. Based on the improvement of
traditional treatment methods and the development of new treatment modes, the pattern of …

The intrinsic limits of conventional cancer therapies prompted the development and
application of various nanotechnologies for more effective and safer cancer treatment …

With the integration of nanotechnology into the medical field at large, great strides have
been made in the development of nanomedicines for tackling different diseases, including …

Remarkable progress has recently been made in the synthesis and characterization of
engineered nanoparticles for imaging and treatment of cancers, resulting in several …

The majority of nanomedicines in (pre) clinical trials are based on established drugs, such
as doxorubicin and paclitaxel. Does that make sense? To some extent yes, because a lot of …

Nanotechnology-based chemotherapeutics and imaging agents represent a new era of
“cancer nanomedicine” working to deliver versatile payloads with favorable …

The emergence of nanomedicine as an innovative and promising alternative technology
shows many advantages over conventional cancer therapies and provides new …

Nanoparticles can provide effective control of the release rate and tissue distribution of their
drug payload, leading to major pharmacokinetic and pharmacodynamic changes vis-à-vis …